Nami Surgical, a medtech startup based in Glasgow, has unveiled a $10 million Series A funding round to enhance its innovative surgical technology. The company’s goal is to transform the field of robotic-assisted surgeries by introducing a miniaturized ultrasonic scalpel. Over the last 18 months, Nami Surgical has strived to bolster its team and bring its core technology to the forefront. To achieve this, cooperation with experienced partners will be vital to their future progress.
In July 2025, Nami Surgical initiated its Series A funding round, which is set to conclude by December 2025. Recently, the company has been backed by previous investors, reaffirming confidence in its strategic direction. Historically, the company managed to accumulate $4.3 million in seed funding by 2024, which has already laid a solid foundation for product development and technological validation through preclinical testing.
What Opportunities Await Interested Investors?
Nami Surgical is reaching out to investors familiar with surgical robotics and medical devices. The raised funds will launch their soft-tissue robotic-assisted surgical platform and extend their reach in the medical field. The utilization of this capital is targeted at strengthening the research and development phase, high-volume prototyping, testing, and exploration in bone-tissue surgery. The company aims to build a robust leadership team for global commercial ventures.
Dr. Nico Fenu, co-founder and CEO of Nami Surgical, stated, “We are now fully focused on our Series A round—an important and defining moment for our team.”
“This funding will unlock an exciting phase of commercial partnerships and shape what’s possible for our ultrasonic platform across multiple verticals,” added Fenu.
How Does Nami Surgical’s Technology Address Existing Barriers?
The challenge with conventional ultrasonic scalpels is their inability to fit into robotic surgical systems due to size constraints. Nami Surgical has tackled this by creating the first miniaturized ultrasonic scalpel that integrates seamlessly with robotic joints and fits through standard surgical ports. This advancement paves the way for precise and efficient minimally invasive procedures.
Beyond the scalpel, Nami Surgical has devised a modular ultrasonic driving system ensuring accurate energy control at surgical sites. The device’s small footprint does not compromise its performance; it parallels current market leaders despite being significantly smaller. This dual capability of precise energy delivery and compact size represents a notable advancement in the field.
This progress indicates a meaningful shift within the surgical robotics industry, with Nami Surgical at the helm of these innovative trends. The intersection of advanced engineering and medical precision creates potential for wider adaptability and integration in hospitals globally.
Nami Surgical’s endeavor highlights the importance of technological miniaturization in surgical applications. By attracting strategic partners and harnessing new funding, they are poised to expand the scope and efficiency of robotic-assisted surgeries. Such initiatives not only enhance the effectiveness of medical procedures but also broaden the platform for future developments in the medtech landscape.
